Skip to content

SYNAPTIK v0.8.0 (Alpha): Patient VCF Ingestion, Drug Repurposing & FDA Pre-IND Package

Choose a tag to compare

@Fr4n0b Fr4n0b released this 12 Nov 19:58
· 16 commits to main since this release

SYNAPTIK v0.8.0 (Alpha): Patient VCF Ingestion, Drug Repurposing, SVG Visualizer & FDA Pre-IND Package

SYNAPTIK v0.8.0 brings four major clinical and regulatory capabilities to the translational neurogenetics platform, bridging raw patient sequencing directly to FDA-ready IND briefing documents.

Highlights & Key Additions

  • Direct Patient Genomic VCF Ingestion & Prioritization Engine (synaptik vcf):
    • Ingests standard Variant Call Format (VCF v4.2 / v4.3) files (.vcf and .vcf.gz) directly from whole-genome (WGS) or whole-exome (WES) sequencing.
    • Automatically resolves ClinVar significance, gnomAD allele frequencies, CADD Phred scores, and SpliceAI donor/acceptor delta scores.
    • Prioritizes cryptic splice-altering variants across core neuro targets (STMN2, UNC13A, SMN2, ELP1, COL6A1, ATXN2, TARDBP, SOD1, FUS).
    • Direct pipeline bridge: synaptik nof1 --vcf <FILE.vcf> auto-extracts high-priority variants and runs the N-of-1 pipeline with zero manual formatting.
  • Small-Molecule Drug Repurposing & CNS Tractability Engine (synaptik repurpose):
    • Curated database of brain-penetrant small-molecule drugs (Risdiplam, Branaplam, Riluzole, Edaravone, Sodium Phenylbutyrate, Memantine, Diazepam, Vorinostat, Rapamycin).
    • Evaluates Physicochemical CNS Multiparameter Optimization (CNS MPO, 0–6 scale) and Blood-Brain Barrier (BBB) penetrance.
    • Directional mechanism-of-action matching (Activator vs Inhibitor vs Modulator).
    • Predicts in vitro and in vivo transcriptomic rescue efficacy percentages and ranks candidates by composite translational rank score.
  • Publication-Grade Splicing & ASO Architecture Vector Visualizer (SVG):
    • Generates publication-ready SVG diagrams rendering pre-mRNA architecture: canonical flanking exons, cryptic exon, splice donor (GT) and acceptor (AG) sites, sashimi-style curved splice junction arcs with $\Delta\Psi$, and tiled 18-mer ASO steric-blocker footprints with base-level sequences.
    • Standalone SVG file export via CLI flags: synaptik aso --svg <PATH.svg> and synaptik nof1 --svg <PATH.svg>.
    • Embedded directly into the laboratory Web UI for real-time visualization and one-click figure export.
  • FDA CDER/CBER Type B Pre-IND Meeting Package Generator:
    • Expands synaptik nof1 with --pre-ind <PATH.md>: produces an audit-ready, 21 CFR Part 312 compliant 10-section eCTD briefing document.
    • Includes CMC specifications, nonclinical pharmacology, 13-week NHP GLP tox study plan, and specific questions for FDA reviewers.
  • Interactive Laboratory Web Dashboard Expansion (synaptik ui):
    • Dedicated Patient VCF tab with text/file upload, sample STMN2 loader, and 1-click "Translate in N-of-1" routing.
    • Dedicated Drug Repurposing tab with interactive drug cards, CNS MPO scores, and clinical phase filters.
    • Embedded interactive vector SVG splicing visualizer with one-click SVG export.
    • One-click Download FDA Pre-IND Package button.
    • REST API endpoints: /api/vcf, /api/repurpose, /api/visualize/splicing, /api/nof1/preind.
  • Scientific Recognition & Attribution:
    • Platform Lead: Francesco Nobile (ORCID: 0009-0001-9477-3332), Center for Genomic Medicine, Massachusetts General Hospital / Harvard Medical School & University of Pavia.
    • Standardized citation output via synaptik cite (BibTeX, APA, Nature format).
  • CI Test Suite: 478 passing checks across 13 test suites on Python 3.10, 3.11, and 3.12.